SEC Form 4 · accession 0001104659-15-002807
SUPERNUS PHARMACEUTICALS, INC. · SUPN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Padmanabh P. Bhatt
Officer — Sr. VP of IP, CSO
Period of report
Jan 15, 2015
Accepted (ET)
Jan 16, 2015 · 9:44 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356576
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 15, 2015 | M | 37,500 | $2.56 | A | 107,306 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $2.56 | Jan 15, 2015 | M | 37,500 | D | — | Nov 2, 2020 | Common Stock | 37,500 | 0 | D |
Explanation of responses
- F1The option became exercisable in four equal installments beginning on November 2, 2011, which was the first anniversary of the date on which the option was granted.